REVOGENEX
Revogenex, Inc. is a research-driven pharmaceutical company dedicated to putting quality first. Established in 2009, Revogenex is dedicated to facing healthcare challenges and improve the overall health of millions of lives by developing, manufacturing, and marketing effective, quality medications throughout the world. The Company devotes extensive efforts to continually improving the way they do business.
REVOGENEX
Industry:
Manufacturing Pharmaceutical Product Research
Founded:
2009-01-01
Address:
Duluth, Georgia, United States
Country:
United States
Website Url:
http://www.revogenex.com
Total Employee:
101+
Status:
Active
Contact:
+117704951935
Technology used in webpage:
SPF LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail Unified Layer HostGator DNS
Current Employees Featured
Founder
Official Site Inspections
http://www.revogenex.com
- Host name: 208.91.197.39
- IP address: 208.91.197.39
- Location: British Virgin Islands
- Latitude: 18.5
- Longitude: -64.5
- Timezone: America/Tortola
More informations about "Revogenex"
Revogenex - Crunchbase Company Profile & Funding
Established in 2009, Revogenex is dedicated to facing healthcare challenges and improve the overall health of millions of lives by developing, manufacturing, and marketing effective, quality โฆSee details»
Organization | Revogenex, Inc.
Revogenex, Inc. Report issue For profit Phase 2 Founded: Duluth GA United States (2009)See details»
Revogenex, Inc. Company Profile | Dillard, GA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Revogenex, Inc. of Dillard, GA. Get the latest business insights from Dun & Bradstreet.See details»
Revogenex - Overview, News & Competitors | ZoomInfo.com
Revogenex, Inc. is a research-driven pharmaceutical company dedicated to putting quality first. Established in 2009, Revogenex is dedicated to facing healthcare challenges and improve the โฆSee details»
Revogenex - Products, Competitors, Financials, Employees, โฆ
Developer of new drug application (NDA) drugs that address a wide range of specialty therapeutic areas. Use the CB Insights Platform to explore Revogenex's full profile.See details»
Revogenex - Crunchbase
Revogenex operates as a pharmaceutical company. Start Free Trial . Chrome ExtensionSee details»
REVOGENEX INC Company Profile | Mumbai, Maharashtra, India ...
Find company research, competitor information, contact details & financial data for REVOGENEX INC of Mumbai, Maharashtra. Get the latest business insights from Dun & Bradstreet.See details»
Revogenex Company Profile -Sales, Contacts, Competitors โ Buzzfile
Revogenex is in the Pharmaceuticals industry within the Wholesale Trade - Nondurable Goods sector and has been in business for approximately 8 years.See details»
Revogenex Inc - LinkedIn
RevoGen Biologics Medical Equipment Manufacturing San Antonio, Texas Revogan Food and Beverage Services Drongen, Oost-VlaanderenSee details»
Revogenex Inc. - BioCentury Company Profiles - BCIQ
Apr 6, 2015ย ยท Revogenex Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Revogenex, Inc Careers and Employment | Indeed.com
Jun 29, 2017ย ยท Find out what works well at Revogenex, Inc from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for โฆSee details»
Revogenex - Contacts, Employees, Board Members, Advisors
Revogenex has 1 current employee profile, Founder, Chairman & CEO Jeffrey H. Ping.See details»
Coronado Biosciences In-Licenses IV Tramadol, a Phase III
NEW YORK, Feb. 18, 2015 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO) has obtained an exclusive license to an intravenous (IV) formulation of โฆSee details»
Revagenix
Sep 26, 2023ย ยท Our mission at Revagenix is to create life-changing antibiotics. We're passionate about moving the needle on the tens of thousands of deaths every year due to drug-resistant โฆSee details»
Coronado Biosciences In-Licenses Revogenex's Pain Drug - Analyst โฆ
Feb 19, 2015ย ยท Coronado Biosciences (CNDO) exclusively licensed a late-stage intravenous (IV) formulation of tramadol for the U.S. market from a privately held pharmaceutical company, โฆSee details»
Revogenex | Insights
Nov 26, 2018ย ยท Revogenex Ireland Ltd. See more in Biomedtracker. Latest on Revogenex. Already A Biomedtracker Subscriber? You have access to the full company record through โฆSee details»
Jeffrey H. Ping - Founder, Chairman & CEO @ Revogenex
Jeffrey H. Ping is the Founder, Chairman, and CEO at Revogenex. He attended The University of Georgia.See details»
Coronado In-Licenses IV Tramadol from Revogenex Ireland
Feb 18, 2015ย ยท Coronado Biosciences said today it has exclusively in-licensed an intravenous (IV) formulation of tramadol for the U.S. from Revogenex Ireland. The deal generated a $2 million โฆSee details»
Revogenex Management Team - CB Insights
Revogenex's current Founder, Chief Executive Officer is Jeffrey Ping. You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data โฆSee details»
Contact - Revagenix
Weโre always looking to connect with others dedicated to building a sustainable antibiotic pipeline and ecosystem. Passionate job-seekers, academics, investors, deal-makers, and other โฆSee details»